Skip to main navigation Skip to search Skip to main content

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment naive patients with compensated cirrhosis: real-world experience from Taiwan HCV registry

  • Chao-Hung Hung
  • , Te-Sheng Chang
  • , Chung-Feng Huang
  • , Hsing-Tao Kuo
  • , Ching-Chu Lo
  • , Chien-Wei Huang
  • , Lee-Won Chong
  • , Pin-Nan Cheng
  • , Ming-Lun Yeh
  • , Cheng-Yuan Peng
  • , Chien-Yu Cheng
  • , Jee-Fu Huang
  • , Ming-Jong Bair
  • , Chih-Lang Lin
  • , Chi-Chieh Yang
  • , Sih-Ren Wang
  • , Tsai-Yuan Hsieh
  • , Tzong-Hsi Lee
  • , Pei-Lun Lee
  • , Wen-Chih Wu
  • Chih-Lin Lin, Wei-Wen Su, Shengshun Yang, Chia-Chi Wang, Jui-Ting Hu, Lien-Juei Mou, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Jia-Sheng Huang, Guei-Ying Chen, Jian-Neng Gao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Chiyi Chen, Kuo-Chih Tseng, Ming-Lung Yu

Research output: Contribution to journal › Journal Article › peer-review

Original languageAmerican English
JournalJournal of Hepatology
Volume77
StatePublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this